Product Images Atomoxetine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Atomoxetine NDC 64980-373 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1: Mean Weight and Height Percentiles Over Time for Patients With Three Years of Atomoxetine Treatment - atomoxetine fig1

Figure 1: Mean Weight and Height Percentiles Over Time for Patients With Three Years of Atomoxetine Treatment - atomoxetine fig1

This appears to be a chart or graph showing the Mean Weight Percentile and Mean Height Percentile for two groups (N=203 and N=155) over a period of 36 months of treatment. However, without further context or information, it is difficult to determine the groups being compared or the type of treatment being evaluated.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (30 Capsules Bottle) - atomoxetine fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (30 Capsules Bottle) - atomoxetine fig2

This is a medication package containing Atomoxetine capsules. The text provides information about the drug dosage, administration, storage, and safety precautions. The medicine is intended to treat certain mental health conditions, and the package includes a batch and expiry code. The text also instructs pharmacists to dispense the medication with the provided guide.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 18 mg (30 Capsules Bottle) - atomoxetine fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 18 mg (30 Capsules Bottle) - atomoxetine fig3

This is a description of Rising® noc 64980-374-03, which is Atomoxetine Capsules. It contains Atomoxetine hydrochloride USP equivalent to atomoxetine 18 mg. It is distributed by Fising Pharmaceuticals, Inc. and made in India. The ususal dosage is provided in the package insert for dosage and administration. It needs to be kept tightly closed and out of reach of children, with excursions permitted to 15 to 30 degrees Celsius. Batch and expiry details are printed during coding. A pharmacist needs to dispense it and a guide is provided separately.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (30 Capsules Bottle) - atomoxetine fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (30 Capsules Bottle) - atomoxetine fig4

Each capsule contains Atomoxetine, a drug used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). This medication is distributed by a company named RiSiNG® in India. The capsules come in a dosage strength of 25 mg and should be kept in a cool and dry place, away from children. Further dosage instructions can be found in the package leaflet provided. The text includes a prescription code and additional information regarding packaging and coding.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 40 mg (30 Capsules Bottle) - atomoxetine fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 40 mg (30 Capsules Bottle) - atomoxetine fig5

This text appears to be describing a medication called ZRISING® Noc 61980-376-03. The text provides information on the manufacturer (Made in India) and the dosage and administration of the medication (Atomoxetine). The capsules should be stored at 20° to 25°C. The text also includes a warning to keep the medication out of the reach of children. The medication comes in a package of 30 capsules and the batch and expiry dates will be printed during coding.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 60 mg (30 Capsules Bottle) - atomoxetine fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 60 mg (30 Capsules Bottle) - atomoxetine fig6

Atomoxetine is a medication available in the form of capsules that contain Atomoxstine hycrochloride. Each capsule is equivalent to atomoxatine 60. There are 30 capsules in this package. Pharmacists are advised to dispense this medication with a provided guide. The manufacturer is Gode/’PRAMCAUTICAS’ from India. Store between 20 to 25°C (68 to T7°F); and excursions permitted 1o 16" 10 30°C: (59° 0 86°F). Keep out of reach of children. This product was reviewed in October 2022. Batch and expiry dates will be printed during coding.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 80 mg (30 Capsules Bottle) - atomoxetine fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 80 mg (30 Capsules Bottle) - atomoxetine fig7

Each capsule of Atomoxetine hydrochloric contains 4mg. This medication is manufactured by Rising Pharmaceuticals in East Brunswick, NJ, USA. The code for the drug is TS/DRUGS/10/1693, and the revision date is 0072022. The medication comes with a separate guidance manual, and the dosage is 30 capsules. The information related to batch and expiry will be printed during coding.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (30 Capsules Bottle) - atomoxetine fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (30 Capsules Bottle) - atomoxetine fig8

This appears to be a description of a medication in the form of a capsule. The medication is called Somocins and is available in a 30 capsule package, with a dosage and administration guide provided separately. The capsules contain tomoxstin hyckrochlorids USP equivalent to Atomoxetine S bses o, o pemeato o3 and have a NDC number of 64980-379-03. The manufacturer is based in East Brunswick, NJ and the revision date for the information provided is 00/2022. However, the text is not entirely clear and some information may be missing or unclear.*

chemical structure - atomoxetine str

chemical structure - atomoxetine str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.